Artivion Announces Presentation of Late-Breaking Data from A

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the presentation of...

Related Keywords

Texas , United States , Canada , San Antonio , Atlanta , Georgia , J Thorac Cardiovasc , Brian Johnston Laine Morgan , Pat Mackin , Wilson Szeto , Lance Berry , Meeting Of The Society Thoracic Surgeons , Gilmartin Group , Prnewswire Artivion Inc , Cardiovascular Surgery At Penn Presbyterian Medical Center , Health Canada , Artivion Inc , Drug Administration , All Cause Mortality , Primary Major Adverse Events , Dissections Complicated , Primary Major , Current Standard , Care Hemi Arch , Late Breaking Science , Annual Meeting , Thoracic Surgeons , Cardiovascular Surgery , Penn Presbyterian Medical Center , Novel Aortic Arch Hybrid Prosthesis , Open Repair , Acute Debakey Typei Dissection , Post Op Paraplegia , Chief Executive Officer , Debakey Typei Aortic , Stanford Type , Thorac Cardiovasc Surg , Thorac Dis , Endovasc Surg , Eurj Cardiothorac Surg , Artivion , Nc ,